Streetbeat News

Stock Prices

SMLR

Semler Scientific reported better-than-expected Q2 financial results, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

August 11, 2023 | 12:33 pm

YTEN

Yield10 Bioscience, Inc. (NASDAQ:YTEN) has announced the pricing of its public offering of 5.75 million units at $0.65 per unit. Each unit consists of one share of common stock and one warrant to purchase one share of common stock. The offering is expected to close on August 15, 2023, and is expected to generate gross proceeds of approximately $3.7 million.

Portfolio Pulse from Happy Mohamed

August 11, 2023 | 12:33 pm

ETON

Eton Pharmaceuticals announced better-than-expected Q2 financial results, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

August 11, 2023 | 12:33 pm

YTEN

Yield10 Biosciences has announced the pricing of a $3.7 million public offering, leading to a decrease in its share price.

Portfolio Pulse from Benzinga Newsdesk

August 11, 2023 | 12:32 pm

AMRS

Amyris Inc. shares are trading higher after a steep selloff yesterday. The selloff was triggered by the company's announcement that it has filed for Chapter 11 bankruptcy.

Portfolio Pulse from Benzinga Newsdesk

August 11, 2023 | 12:32 pm

SPY

The USA Producer Price Index (PPI) for July has increased to 0.8%, exceeding the estimated 0.7% and the prior value of 0.2%.

Portfolio Pulse from Benzinga Newsdesk

August 11, 2023 | 12:31 pm

SPY

The Core Producer Price Index (PPI) for July has come in at 2.4%, slightly higher than the estimated 2.3%.

Portfolio Pulse from Benzinga Newsdesk

August 11, 2023 | 12:31 pm

SPY

The USA Core Producer Price Index (PPI) for July increased by 0.3%, beating the estimated 0.2% and showing a significant improvement from the -0.1% in the prior month.

Portfolio Pulse from Happy Mohamed

August 11, 2023 | 12:30 pm

SPY

The Producer Price Index (PPI) for July has come in at 0.3%, higher than the estimated 0.2%.

Portfolio Pulse from Benzinga Newsdesk

August 11, 2023 | 12:30 pm

BTCY

Biotricity Inc. (NASDAQ:BTCY) has reported strong Q1-FY2024 recurring revenue growth, higher margins on technology fees, and control over sales and technology expenses through automation and AI. The company is showing continued growth and strength in its fundamentals, moving towards profitability. The company's management is focused on monitoring adjusted EBITDA to track progress towards achieving positive net operating cash flows.

Portfolio Pulse from Happy Mohamed

August 11, 2023 | 12:29 pm